Role of the conserved threonine 309 in mechanism of oxidation by cytochrome P450 2D6 |
| |
Authors: | Keizers Peter H J Schraven Loek H M de Graaf Chris Hidestrand Mats Ingelman-Sundberg Magnus van Dijk Ben R Vermeulen Nico P E Commandeur Jan N M |
| |
Affiliation: | Leiden Amsterdam Center for Drug Research (LACDR), Division of Molecular Toxicology, Department of Pharmacochemistry, Vrije Universiteit, De Boelelaan 1083, 1081 HV Amsterdam, The Netherlands. |
| |
Abstract: | Based on sequence alignments and homology modeling, threonine 309 in cytochrome P450 2D6 (CYP2D6) is proposed to be the conserved I-helix threonine, which is supposed to be involved in dioxygen activation by CYPs. The T309V mutant of CYP2D6 displayed a strong shift from O-dealkylation to N-dealkylation reactions in oxidation of dextromethorphan and 3,4-methylenedioxymethylamphetamine. This may be explained by an elevated ratio of hydroperoxo-iron to oxenoid-iron of the oxygenating species. In consistence, using cumene hydroperoxide, which directly forms the oxenoid-iron, the T309V mutant again selectively catalyzed the O-dealkylation reactions. The changed ratio of oxygenating species can also explain the decreased activity and changed regioselectivity that were observed in 7-methoxy-4-(aminomethyl)-coumarin and bufuralol oxidation, respectively, by the T309V mutant. Interestingly, the T309V mutant always showed a significantly increased, up to 75-fold, higher activity compared to that of the wild-type when using cumene hydroperoxide. These results indicate that T309 in CYP2D6 is involved in maintaining the balance of multiple oxygenating species and thus influences substrate and regioselectivity. |
| |
Keywords: | Cytochrome P450 2D6 T309V mutant T312V mutant Product ratio Allosteric effects Reactive oxygen species |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|